Neurochemical regulators of food behavior for pharmacological treatment of obesity: current status and future prospects

Future Med Chem. 2020 Oct;12(20):1865-1884. doi: 10.4155/fmc-2019-0361. Epub 2020 Oct 12.

Abstract

In recent decades, obesity has become a pandemic disease and appears to be an ultimate medical and social problem. Existing antiobesity drugs show low efficiency and a wide variety of side effects. In this review, we discuss possible mechanisms underlying brain-gut-adipose tissue axis, as well as molecular biochemical characteristics of various neurochemical regulators of body weight and appetite. Multiple brain regions are responsible for eating behavior, hedonic eating and food addiction. The existing pharmacological targets for treatment of obesity were reviewed as well.

Keywords: anti-obesity drugs; hypothalamus; neurochemical regulators; obesity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adipose Tissue / drug effects
  • Adipose Tissue / metabolism
  • Animals
  • Anti-Obesity Agents / pharmacology*
  • Body Weight / drug effects
  • Brain / drug effects
  • Brain / metabolism
  • Feeding Behavior / drug effects*
  • Gastrointestinal Microbiome / drug effects
  • Humans
  • Obesity / drug therapy*
  • Obesity / metabolism
  • Transcription Factors / metabolism*

Substances

  • Anti-Obesity Agents
  • Transcription Factors